Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001628280-23-011502
Filing Date
2023-04-13
Accepted
2023-04-13 16:08:12
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-04-13

Document Format Files

Seq Description Document Type Size
1 ARS esperion2022annualreportdi.pdf ARS 2101274
  Complete submission text file 0001628280-23-011502.txt   2890252
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-35986 | Film No.: 23818454
SIC: 2834 Pharmaceutical Preparations